Genprex Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Genprex Contact Number

Contact Genprex

2 hours ago Genprex.com Show details

Corporate Headquarters 3300 Bee Cave Road, Suite 650-227Austin, TX 78746 Phone: (877) 774-GNPX (4679)

Category: Contact SupportShow more

Genprex Crunchbase Company Profile & Funding

7 hours ago Crunchbase.com Show details

Contact Email [email protected]genprex.com. Phone Number (512)537-7997. Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and

Founded: 2009
Founder: J Rodney Varner

Category: Contact NumberShow more

Genprex Reprogramming the course of cancer and diabetes

4 hours ago Genprex.com Show details

Genprex’s oncology drug development program utilizes its unique, proprietary, non-viral ONCOPREX® Nanoparticle Delivery System, which the Company believes is the first systemic gene therapy delivery platform used for cancer in humans.

Category: Contact NumberShow more

Genprex, Inc. Company Profile Austin, TX Competitors

5 hours ago Dnb.com Show details

(877) 774-4679

Genprex, Inc. is located in Austin, TX, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Genprex, Inc. has 5 total employees across all of its locations. There are 2 companies in the Genprex, Inc. corporate family.

Employees: 5
Phone: (877) 774-4679
Location: 1601 Trinity St Bldg B, Austin, 78712-1765, TX

Category: Contact NumberShow more

About Genprex

Just Now Genprex.com Show details

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options.

Estimated Reading Time: 3 mins

Category: Contact NumberShow more

Shareholder FAQ Genprex

Just Now Genprex.com Show details

(212) 828-8436

Please contact our transfer agent, V Stock Transfer, LLC, through their website or by phone at (212) 828-8436. The company can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates.

Category: Contact NumberShow more

Genprex, Inc. in Cambridge, MA Company Info & Reviews

5 hours ago Bizapedia.com Show details

Genprex, Inc. is a Massachusetts Foreign Corporation filed On January 8, 2019. The company's File Number is listed as 001362711. The Registered Agent on file for this company is Ryan Confer and is located at 1 Broadway, 14th Floor, Cambridge, MA 02142.

Location: MA

Category: Contact NumberShow more

Genprex Issues Shareholder Letter and Provides Corporate

1 hours ago Nasdaq.com Show details

Genprex, Inc. (877) 774-GNPX (4679) Investor Relations GNPX Investor Relations (877) 774-GNPX (4679) ext. #2 [email protected]genprex.com Media Contact Genprex Media Relations Kalyn Dabbs (877) 774-GNPX

Category: Contact NumberShow more

Genprex, Inc. Home Facebook

6 hours ago Facebook.com Show details

Genprex, Inc., Austin, Texas. 24,535 likes · 63 talking about this. Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.

Category: Home PhoneShow more

Genprex Strengthens Management Team with Appointments of

7 hours ago Us.acrofan.com Show details

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options.

Category: Contact NumberShow more

Genprex Company Profile Office Locations, Competitors

4 hours ago Craft.co Show details

Genprex is a gene therapy company developing treatments for cancer and diabetes. Its cancer therapies are based upon a technology platform, including its lead drug candidate, Oncoprex immunogene therapy, or Oncoprex, for non-small cell lung cancer that consists of a tumor suppressor gene inserted into a patient’s cells that has immunomodulatory effects.

Category: Contact NumberShow more

Genprex, Inc. (Form: 10Q, Received: 08/14/2018 17:15:23)

4 hours ago Content.edgar-online.com Show details

Commission file number: 001-38244 GENPREX, INC. (Exact name of registrant as specified in its charter) Delaware 90 - 0772347 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 1701 Trinity Street, Suite 3.322, Austin, TX 78712 (Address of principal executive offices)

Category: Contact NumberShow more

Genprex Issues Shareholder Letter and Provides Corporate

8 hours ago Finance.yahoo.com Show details

Media Contact Genprex Media Relations Kalyn Dabbs (877) 774-GNPX (4679) ext. #3 GameStop, Inc. in alleged scheme that netted them hundreds of …

Category: Contact NumberShow more

Genprex, Inc. (GNPX) Company Profile & Overview Stock

6 hours ago Stockanalysis.com Show details

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes who currently have limited treatment options.

Category: Contact NumberShow more

Genprex Strengthens Management Team with Appointments of

4 hours ago Finance.yahoo.com Show details

Media Contact Genprex Media Relations Anne Marie Fields (877) 774-GNPX (4679) ext. #3 [email protected] Recommended Stories. Motley …

Category: Contact NumberShow more

Genprex Issues Shareholder Letter and Provides Corporate

3 hours ago Genprex.com Show details

AUSTIN, Texas — (February 1, 2021) — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced today that it has issued a shareholder letter and corporate update outlining the Company’s developments and initiatives for 2020 and anticipated

Category: Contact NumberShow more

Genprex Announces Formation of Clinical Advisory Board

1 hours ago Finance.yahoo.com Show details

Media Contact Genprex Media Relations Kalyn Dabbs (877) 774-GNPX (4679) ext. #3 [email protected]genprex.com. there are some surprises among the small number of …

Category: Contact NumberShow more

GENPREX INC Number of Employees 20172021 GNPX …

8 hours ago Macrotrends.net Show details

GENPREX INC number of employees from 2017 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

Genprex Expands Operations to Cambridge, Mass Genprex

4 hours ago Genprex.com Show details

CAMBRIDGE, MA / ACCESSWIRE / April 25, 2018 / Genprex, Inc.(NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that it has established offices in Cambridge, Mass. to help accelerate the clinical development of its lead drug candidate, Oncoprex™, for the treatment of …

Category: Contact NumberShow more

Gnpxex103_159.htm SEC.gov

8 hours ago Sec.gov Show details

(ii)a number of Shares equal to the number of shares of common stock of the Company subject to outstanding awards granted under the Genprex, Inc. 2009 Stock Plan that, after the Registration Date, expire or otherwise terminate without having been exercised in full and a number of Shares equal to the number of Shares of common stock of the

Category: Contact NumberShow more

Genprex to Present at the 2020 LD Micro Virtual Conference

8 hours ago Genprex.com Show details

AUSTIN, Texas & CAMBRIDGE, Mass.— (March 3, 2020) — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases, today announced it will be presenting at the third annual LD Micro Virtual Conference on Wednesday, March 4 at 1:40 p.m. EST. Genprex’s …

Category: Contact NumberShow more

GNPX 13F Hedge Fund and Asset Management Owners

4 hours ago Whalewisdom.com Show details

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options.

Category: Contact NumberShow more

Genprex, Inc. (Form: 8K, Received: 05/10/2018 17:17:56)

3 hours ago Content.edgar-online.com Show details

GENPREX, INC. (Exact name of registrant as specified in its charter) Delaware 001-38244 90 - 0772347 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification Number) 100 Congress Avenue, Suite 2000, Austin, TX 78701 (Address of principal executive offices) (Zip Code) Registrant

Category: Contact NumberShow more

GNPX News Financial News Media

5 hours ago Financialnewsmedia.com Show details

Genprex undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. (877) 774-GNPX (4679) Investor Relations GNPX Investor Relations (877) 774-GNPX (4679) ext. #2 [email protected]genprex.com. Media Contact Genprex Media Relations Kalyn Dabbs (877) 774-GNPX (4679

Category: Contact NumberShow more

GNPX Genprex Inc. Stock Price & News WSJ

6 hours ago Wsj.com Show details

News Genprex Inc.GNPX. No news for in the past two years. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of

Category: Contact NumberShow more

Genprex Announces $1.26 Million Registered Direct Offering

8 hours ago Nasdaq.com Show details

Genprex, Inc. (877) 774-GNPX (4679) Investor Relations GNPX Investor Relations (877) 774-GNPX (4679) ext. #2 [email protected]genprex.com Media Contact Genprex Media Relations Kalyn Dabbs (877) 774-GNPX

Category: Contact NumberShow more

Genprex to Participate in September Investor Conferences

6 hours ago Finance.yahoo.com Show details

Media Contact Genprex Media Relations Kalyn Dabbs (877) 774-GNPX (4679) ext. #3 [email protected]genprex.com despite the increasing number of cases in …

Category: Contact NumberShow more

Genprex Recognizes World Cancer Day Yahoo Finance

1 hours ago Finance.yahoo.com Show details

Media Contact Genprex Media Relations Kalyn Dabbs (877) 774-GNPX (4679) ext. #3 [email protected]genprex.com Innovative Industrial stock's 1-year return has outperformed a …

Category: Contact NumberShow more

Genprex to Present at NobleCon17 on January 19

3 hours ago Finance.yahoo.com Show details

The report reviewed Channelchek’s most popular content from 2020, and found that a research note on Genprex took the number one spot for being the most read research report of …

Category: Contact NumberShow more

Ryan M. Confer Chief Financial Officer Genprex, Inc

8 hours ago Linkedin.com Show details

Confer Capital, Inc. Jun 2008 - Present12 years 11 months. Austin, Texas Area. Confer Capital, Inc is a technology commercialization advisory services boutique. Our core competency focuses on the

Title: Chief Financial Officer at …
Location: Austin, Texas
1. 500+ connections

Category: Contact NumberShow more

Genprex Inc. (NASDAQ: GNPX) IBN (InvestorBrandNetwork)

7 hours ago Investorbrandnetwork.com Show details

Genprex Inc. (NASDAQ: GNPX) Genprex Inc. is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC).Genprex’s platform technologies are designed to administer cancer

Category: Contact NumberShow more

Genprex to Receive Inaugural "License of the Year" Award

5 hours ago Finance.yahoo.com Show details

Genprex will receive the License of the Year award from University of Pittsburgh on April 22 for advances made on gene therapy program in diabetes. considering the …

Category: Contact NumberShow more

Genprex : to Present at the Alliance for Regenerative

7 hours ago Marketscreener.com Show details

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it will be presenting at the Alliance for Regenerative Medicine’s (ARM) virtual Cell and Gene Meeting on the Mesa, taking place October 12-16, 2020.

Category: Contact NumberShow more

Genprex Enters Into Exclusive Worldwide Patent and

7 hours ago Businesswire.com Show details

Media Contact Genprex Media Relations Kalyn Dabbs (877) 774-GNPX (4679) ext. #3 [email protected]genprex.com Release Summary Genprex Signs Exclusive Worldwide License Agreement with MD Anderson Cancer Center

Category: Contact NumberShow more

Genprex, Inc. CEO discusses how their Immunogene Therapy

2 hours ago Ceocfointerviews.com Show details

Contact: (877) 774-GNPX [email protected]genprex.com Interview conducted by: Lynn Fosse, Senior Editor developed for more than 10 years, have identified a number of different ways that it works. They refer to it as a multi factorial agent in that it has multiple mechanisms of action. It is known to modulate cell signaling, which is the method

Category: Contact NumberShow more

FDA Fast Track on Lung Cancer Treatment Brings Exponential

2 hours ago 247wallst.com Show details

Genprex showed that this is a higher number of deaths than from colon cancer, breast cancer and prostate cancer combined. In the United States alone, the …

Category: Contact NumberShow more

Genprex, Inc. YouTube

6 hours ago Youtube.com Show details

Genprex (GNPX) is a clinical-stage biopharmaceutical company developing novel gene therapies to improve outcomes for cancer patients receiving promising targeted and immunotherapies, as well as to

Category: Contact NumberShow more

Gnpxex101_59.htm SEC

4 hours ago Sec.gov Show details

(a)Consultant recognizes that in performance under this Agreement he will have contact with materials and information of substantial value to Genprex that is not generally known outside Genprex. Consultant will not, at any time (except as authorized in writing by Genprex), divulge or disclose, directly or indirectly, to any person, firm

Category: Contact NumberShow more

Should You Accumulate Genprex Inc (GNPX) in Biotechnology

6 hours ago Investorsobserver.com Show details

Genprex Inc is near the top in its industry group according to InvestorsObserver.GNPX gets an overall rating of 53. That means it scores higher than 53 percent of stocks. Genprex Inc gets a 84 rank in the Biotechnology industry. Biotechnology is number 102 out of 148 industries.

Category: Tech SupportShow more

Genprex, Inc. 10Q Aug. 13, 2021 4:34 PM Seeking Alpha

9 hours ago Seekingalpha.com Show details

Commission file number: 001-38244 GENPREX, INC. (Exact name of registrant as specified in its charter) Delaware. 90-0772347 (State or other jurisdiction of (I.R.S. Employer

Category: Contact NumberShow more

CEORoadshow 2021 Webinar Series Presents Genprex, Inc

9 hours ago Ceoroadshow.com Show details

December 15, 2021 11:00 AM EDT. January 26, 2021 11:00 AM EDT. This Webinar is part of the CEO Roadshow Webinar Series where we feature small and mid-cap stocks that are on the verge of a breakout or have other near-term developments making them an attractive long-term investment opportunity. In this webinar, we will be joined by Rodney Varner

Category: Contact NumberShow more

GNPX: Average Analyst Price Target is $6.5

6 hours ago Stocknews.com Show details

GNPX has a greater number of analysts covering the stock than 13.06% of Healthcare stocks. The variance in analysts' estimates of GNPX is less than 15.29% of stocks in the micro market cap category. Stocks similar to Genprex Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ACOR, XBIO and OSMT.

Category: Contact NumberShow more

Gnpx20190911_8k.htm

1 hours ago Sec.gov Show details

749-20-0018

0001437749-20-001850.txt : 20200206 0001437749-20-001850.hdr.sgml : 20200206 20200206082027 accession number: 0001437749-20-001850 conformed submission type: 8-k public document count: 2 conformed period of report: 20200206 item information: other events item information: financial statements and exhibits filed as of date: 20200206 date as of change: 20200206 filer: company data: …

Category: Contact NumberShow more

Genprex Inc. (NASDAQ: GNPX) Could Post A 61.62% Or More

9 hours ago Marketingsentinel.com Show details

During the last session, Genprex Inc. (NASDAQ:GNPX)’s traded shares were 0.35 million, with the beta value of the company hitting -0.95. At the end of the trading day, the stock’s price was $3.07, reflecting an intraday loss of -6.97% or -$0.23. The 52-week high for the GNPX share is $7.

Category: Contact NumberShow more

Shop Hatchery

4 hours ago Shophatchery.com Show details

There are a number of points that contribute to an excellent photo. Often nailing simply one of these points can carry a photo to success. A Concise Trading Overview Of …

Category: Contact NumberShow more

It’s Worth A Gamble To Have A Position In Genprex Inc

4 hours ago Marketingsentinel.com Show details

Genprex Inc. (NASDAQ:GNPX)’s traded shares stood at 0.49 million during the last session, with the company’s beta value hitting -0.92. At the close of trading, the stock’s price was $2.85, to imply an increase of 4.78% or $0.13 in intraday trading. The GNPX share’s 52 …

Category: Contact NumberShow more

Genprex Trimming PT to $12 But Maintain Buy Rating

9 hours ago Choresearch.com Show details

Disclosure: Cho Research was compensated to publish “ Genprex Trimming PT to $12 But Maintain Buy Rating ” The to-date compensation terms were $15,000 cash and 15,000 shares via options over a 7-year contract duration as of January 2019. Though Cho Research does use the research dollars it. reports such as this.

Category: Contact NumberShow more

Genprex Target Price GNPX

3 hours ago Macroaxis.com Show details

The current analyst and expert consensus on Genprex is Buy, with 0 strong sell and 1 strong buy opinions. The current projected Genprex target price consensus is 7.0 with 1 analyst opinions. The most common way Genprex analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Genprex executives and customers to further validate their buy

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Godrej
Gic
Gbl
Gpa
Gaia
Gati
Geely
Geron
Gevo